慢性閉塞性肺疾患の世界市場：市場規模・現状・予測

• 英文タイトル：Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03852 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、慢性閉塞性肺疾患の世界市場について調査・分析し、慢性閉塞性肺疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（短時間作用型気管支拡張剤、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張剤、ホスホジエステラーゼ-4阻害剤、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性閉塞性肺疾患市場動向 ・主要企業別マーケットシェア ・慢性閉塞性肺疾患の種類別市場規模2014-2019 （短時間作用型気管支拡張剤、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張剤、ホスホジエステラーゼ-4阻害剤、その他） ・慢性閉塞性肺疾患の用途別市場規模2014-2019 （病院、診療所、その他） ・慢性閉塞性肺疾患の北米市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の中国市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の日本国内市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の東南アジア市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患のインド市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GSK、Pfizer、Merck、Novartis、AstraZeneca、Boehringer Ingelheim、Teva Pharmaceuticals、Ario Pharma、Roche、Ache、Almirall、Aquinox Pharmaceuticals、Asmacure、Astellas Pharma） ・慢性閉塞性肺疾患の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.The growth of the global chronic obstructive pulmonary disease (COPD) market is expected to be fueled by a high number of new, more efficacious and convenient products entering the market and commanding a greater value compared to the therapies already existing in the market. Another major factor propelling the growth of the market is the introduction of novel innovations like ultrasonic nebulizers, which are superior to the existing jet nebulizers. The competitive environment is expected to intensify with an increase in product extensions, technological innovations, and an increase in the number of mergers and acquisitions. The market for COPD drugs shows potential opportunity in both developed and developing countries. Due to the effectiveness and advancements in technology, many companies are focusing and collaborating to develop innovative COPD drugs and treatments.
In 2018, the global Chronic Obstructive Pulmonary Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Chronic Obstructive Pulmonary Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Obstructive Pulmonary Disorder development in United States, Europe and China.

The key players covered in this study
GSK
Pfizer
Merck
Novartis
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceuticals
Ario Pharma
Roche
Ache
Almirall
Aquinox Pharmaceuticals
Asmacure
Astellas Pharma

Market segment by Type, the product can be split into
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Chronic Obstructive Pulmonary Disorder status, future forecast, growth opportunity, key market and key players.
To present the Chronic Obstructive Pulmonary Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Obstructive Pulmonary Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Short-Acting Bronchodilators
1.4.3 Corticosteroids
1.4.4 Methylxanthines
1.4.5 Long-Acting Bronchodilators
1.4.6 Phosphodiesterase-4 Inhibitors
1.4.7 Others
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chronic Obstructive Pulmonary Disorder Market Size
2.2 Chronic Obstructive Pulmonary Disorder Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disorder Market Size by Regions (2014-2025)
2.2.2 Chronic Obstructive Pulmonary Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Chronic Obstructive Pulmonary Disorder Market Size by Manufacturers
3.1.1 Global Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2014-2019)
3.1.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Obstructive Pulmonary Disorder Key Players Head office and Area Served
3.3 Key Players Chronic Obstructive Pulmonary Disorder Product/Solution/Service
3.4 Date of Enter into Chronic Obstructive Pulmonary Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019)

5 United States
5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
5.2 Chronic Obstructive Pulmonary Disorder Key Players in United States
5.3 United States Chronic Obstructive Pulmonary Disorder Market Size by Type
5.4 United States Chronic Obstructive Pulmonary Disorder Market Size by Application

6 Europe
6.1 Europe Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
6.2 Chronic Obstructive Pulmonary Disorder Key Players in Europe
6.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type
6.4 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application

7 China
7.1 China Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
7.2 Chronic Obstructive Pulmonary Disorder Key Players in China
7.3 China Chronic Obstructive Pulmonary Disorder Market Size by Type
7.4 China Chronic Obstructive Pulmonary Disorder Market Size by Application

8 Japan
8.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
8.2 Chronic Obstructive Pulmonary Disorder Key Players in Japan
8.3 Japan Chronic Obstructive Pulmonary Disorder Market Size by Type
8.4 Japan Chronic Obstructive Pulmonary Disorder Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
9.2 Chronic Obstructive Pulmonary Disorder Key Players in Southeast Asia
9.3 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Type
9.4 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Application

10 India
10.1 India Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
10.2 Chronic Obstructive Pulmonary Disorder Key Players in India
10.3 India Chronic Obstructive Pulmonary Disorder Market Size by Type
10.4 India Chronic Obstructive Pulmonary Disorder Market Size by Application

11 Central & South America
11.1 Central & South America Chronic Obstructive Pulmonary Disorder Market Size (2014-2019)
11.2 Chronic Obstructive Pulmonary Disorder Key Players in Central & South America
11.3 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Type
11.4 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Application

12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Obstructive Pulmonary Disorder Introduction
12.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Obstructive Pulmonary Disorder Introduction
12.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Obstructive Pulmonary Disorder Introduction
12.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Obstructive Pulmonary Disorder Introduction
12.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Obstructive Pulmonary Disorder Introduction
12.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Obstructive Pulmonary Disorder Introduction
12.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.6.5 Boehringer Ingelheim Recent Development
12.7 Teva Pharmaceuticals
12.7.1 Teva Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Obstructive Pulmonary Disorder Introduction
12.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.7.5 Teva Pharmaceuticals Recent Development
12.8 Ario Pharma
12.8.1 Ario Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Obstructive Pulmonary Disorder Introduction
12.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.8.5 Ario Pharma Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Obstructive Pulmonary Disorder Introduction
12.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.9.5 Roche Recent Development
12.10 Ache
12.10.1 Ache Company Details
12.10.2 Company Description and Business Overview
12.10.3 Chronic Obstructive Pulmonary Disorder Introduction
12.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
12.10.5 Ache Recent Development
12.11 Almirall
12.12 Aquinox Pharmaceuticals
12.13 Asmacure
12.14 Astellas Pharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Chronic Obstructive Pulmonary Disorder Key Market Segments
Table Key Players Chronic Obstructive Pulmonary Disorder Covered
Table Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type 2014-2025
Figure Short-Acting Bronchodilators Figures
Table Key Players of Short-Acting Bronchodilators
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Methylxanthines Figures
Table Key Players of Methylxanthines
Figure Long-Acting Bronchodilators Figures
Table Key Players of Long-Acting Bronchodilators
Figure Phosphodiesterase-4 Inhibitors Figures
Table Key Players of Phosphodiesterase-4 Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Chronic Obstructive Pulmonary Disorder Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Chronic Obstructive Pulmonary Disorder Report Years Considered
Table Global Chronic Obstructive Pulmonary Disorder Market Size 2014-2025 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions 2014-2025 (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions 2014-2019 (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2014-2019
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2014-2019
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2019
Table Market Top Trends
Table Global Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers in 2018
Table Global Chronic Obstructive Pulmonary Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Obstructive Pulmonary Disorder Product/Solution/Service
Table Date of Enter into Chronic Obstructive Pulmonary Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disorder Market Size Share by Application (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application in 2018
Figure United States Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table United States Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table United States Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table United States Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table United States Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure Europe Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure China Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table China Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-20189) (Million US$)
Table China Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table China Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table China Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table Japan Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table Japan Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure India Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table India Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table India Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table India Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table India Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Figure Central & South America Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019)
Table Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019)
Table Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table GSK Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Ario Pharma Company Details
Table Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Ario Pharma Recent Development
Table Roche Company Details
Table Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Roche Recent Development
Table Ache Company Details
Table Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$)
Figure Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019)
Table Ache Recent Development
Table Almirall Company Details
Table Aquinox Pharmaceuticals Company Details
Table Asmacure Company Details
Table Astellas Pharma Company Details
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2025
Figure United States Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Product (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Product in 2025
Table Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---